60 Degrees Pharmaceuticals, Inc.
SXTPCIK 0001946563 · Every Form 4 filed by insiders at this issuer. See financials →
Annual report (10-K)
Latest 10-K filed Mar 30, 2026. Sentiment + YoY language diff vs prior year. Read sections →
Signal:NeutralFull-doc fallback
Full filing:tone -0.0056
Sentiment via Loughran-McDonald lexicon · YoY diff via Jaccard similarity + paragraph set difference.
Recent 8-K announcements
Per-item disclosure feed. Item 2.02 is the earnings release.
Top insiders
Most active reporters at 60 Degrees Pharmaceuticals, Inc.
| Name | Roles | Filings |
|---|---|---|
| Field Paul | Director | 1 |
| Knight Therapeutics International SA | - | 1 |
| Knight Therapeutics Inc | - | 1 |
| Toovey Stephen | Director | 1 |
Showing 6-9 of 9
PrevPage 2 of 2
Top performers
Insiders ranked by realized 90-day signed return on their open-market trades at 60 Degrees Pharmaceuticals, Inc.. Minimum 3 scored trades. Returns are signed - a sale followed by a rally counts against the insider.
| # | Insider | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|
| 1 | Xu Cheryl | 11 | 0% | -61.9% | -75.2% | -17.9% | -77.5% |
| 2 | Dow Geoffrey S | 10 | 0% | -45.8% | -43.3% | -7.9% | -79.9% |
All filings
26 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|